Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Net Cash Flow: 2016-2021

Historic Net Cash Flow for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to -$2.3 million.

  • ENDRA Life Sciences' Net Cash Flow fell 167.90% to -$2.3 million in Q4 2021 from the same period last year, while for Dec 2021 it was $2.2 million, marking a year-over-year increase of 112.15%. This contributed to the annual value of $395,574 for FY2024, which is 119.25% up from last year.
  • Latest data reveals that ENDRA Life Sciences reported Net Cash Flow of -$2.3 million as of Q4 2021, which was down 3.62% from -$2.3 million recorded in Q3 2021.
  • ENDRA Life Sciences' Net Cash Flow's 5-year high stood at $9.6 million during Q1 2021, with a 5-year trough of -$3.1 million in Q1 2020.
  • In the last 3 years, ENDRA Life Sciences' Net Cash Flow had a median value of -$2.0 million in 2019 and averaged $249,180.
  • As far as peak fluctuations go, ENDRA Life Sciences' Net Cash Flow crashed by 21,648.18% in 2018, and later spiked by 39,075.66% in 2020.
  • Quarterly analysis of 5 years shows ENDRA Life Sciences' Net Cash Flow stood at -$1.4 million in 2017, then surged by 524.13% to $5.8 million in 2018, then tumbled by 33.17% to $3.9 million in 2019, then decreased by 11.92% to $3.4 million in 2020, then slumped by 167.90% to -$2.3 million in 2021.
  • Its last three reported values are -$2.3 million in Q4 2021, -$2.3 million for Q3 2021, and -$2.8 million during Q2 2021.